Hema Now: Personalised Medicine and Immunotherapy in Multiple Myeloma
Kenneth Anderson, leading haematology expert at Dana-Farber, shares insights on multiple myeloma, drug resistance, key ASH updates, and turning laboratory research into clinical treatments.